Article Details

GlaxoSmithKline backs under fire CEO and adds Parkinson's and Alzheimer's drugs

Retrieved on: 2021-07-02 11:59:52

Tags for this article:

Click the tags to see associated articles and topics

GlaxoSmithKline backs under fire CEO and adds Parkinson's and Alzheimer's drugs. View article details on HISWAI: http://www.proactiveinvestors.co.uk/companies/news/953998/glaxosmithkline-backs-under-fire-ceo-and-adds-parkinson-s-and-alzheimer-s-drugs-953998.html

Excerpt

... for Parkinson's Disease and Alzheimer's through a deal with US-listed Alector's (NASDAQ:ALEC) for its monoclonal antibodies AL001 and AL101.

Article found on: www.proactiveinvestors.co.uk

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up